INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
93 hedge funds and large institutions have $38.6M invested in Infinity Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 37 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
54% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 37
Holders
93
Holding in Top 10
–
Calls
$471K
Puts
$107K
Top Buyers
| 1 | +$674K | |
| 2 | +$319K | |
| 3 | +$300K | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$174K |
| 5 |
Morgan Stanley
New York
|
+$168K |
Top Sellers
| 1 | -$1.73M | |
| 2 | -$786K | |
| 3 | -$529K | |
| 4 |
CC
Callan Capital
La Jolla,
California
|
-$329K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$323K |